Richard Allan Zeien, age 62 of New Hampton, passed away surrounded by his family on Sunday, Jan. 26, 2025, from complications ...
Piper Sandler analyst maintains an Overweight rating on Teva, citing positive feedback on duvakitug's potential in treating ...
Inc. (NYSE American: PTN), a small-cap biotech company with a market capitalization of $20.4 million, has announced its corporate milestones for 2025, focusing on the development of treatments for ...
2025 Q3 Financial Results (as of September 30, 2025) ...
The FDA has accepted Alvotech (ALVO) and Teva's (TEVA) applications for AVT05, their proposed biosimilar to J&J's ...
A recent study published in the journal Medicine has found a possible connection between low vitamin D levels and increased ...
Three players in the biosimilar space have already sparked hope for the new year, with each having big business or regulatory ...
The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...
Wrist-worn devices can predict imminent inflammatory and symptomatic inflammatory bowel disease flare-ups as far in advance ...
Women with inflammatory bowel disease who delivered a twin gestation pregnancy had higher rates of preterm delivery and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback